Felix Potocnik

Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease

Henry Brodaty, Jody Corey‐Bloom, Felix Potocnik et al. · Dementia and Geriatric Cognitive Disorders · 2005 · 119 citations

FUS and TDP43 genetic variability in FTD and CBS

Edward D. Huey, Raffaele Ferrari, Jorge Moreno et al. · Neurobiology of Aging · 2011 · 84 citations · Full text

Genetics, Genetic Factor, Genetic Variation +4

Increased frequency of the transferrin C2 subtype in Alzheimerʼs disease

Susan J. van Rensburg, Machteid E. Carstens, Felix Potocnik et al. · Neuroreport · 1993 · 67 citations

Alzheimerʼs Disease, Genetic Epidemiology, Tf C2 +16

Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis

Susan J. van Rensburg, Maritha J. Kotze, Dinie Hon et al. · Metabolic Brain Disease · 2006 · 52 citations

Iron Metabolism, Vitamin B Complex, Neurology +5

Genetic Variability in <i>CHMP2B</i> and Frontotemporal Dementia

Parastoo Momeni, Ekaterina Rogaeva, Vivianna M. Van Deerlin et al. · Neurodegenerative Diseases · 2006 · 48 citations

Ftd Families, Corticobasal Degeneration, Genetics +17